If you attended the live event and would like to receive credit please log in.
|
|
Type:
|
Seminar
|
|
|
Date(s):
|
08/25/09
|
|
Times:
|
6:30 PM - 8:30 PM CT
|
|
Facility:
|
Radisson Quad City Plaza |
| |
Davenport , IA
|
|
Contact(s):
|
ProCE Staff
630-540-2848
info@proce.com
|
|
Fee:
|
No Charge!
|
| Course Category: |
This activity has been designated as Knowledge-Based
|
|
Live CE Information
|
ProCE Presents a Complimentary Pharmacy Dinner CE Program on Parkinson's Disease.
|
|
Courses Offered
|
Parkinson's Disease: An Update for the Non-Neurologist (Aug 25, 2009 - Davenport, IA)
|
Details:
Program Location
Radisson Quad City Plaza
Quad City Ballroom
111 East Second Street
Davenport, IA
(563) 322-2200
Program Agenda
6:30 p.m. Registration
7:00 p.m. Dinner
7:30 p.m. CE Presentation
8:30 p.m. Adjourn
Learning Objectives
At the completion of this program, the participant will be able to:
- List 3 cardinal features of Parkinson's Disease
- Compare and contrast the efficacy and safety of dopamine agonists, levodopa, and monoamine oxidase inhibitors
- Describe the motor complications associated with levodopa
- Define the concept of neuroprotection
- Identify non-pharmacologic therapy for Parkinson's Disease
Faculty
Jack J. Chen, PharmD, FCCP, BCPS, CGP
Associate Professor - Neurology
Movement Disorders Clinic
Loma Linda University
Schools of Medicine and Pharmacy
Loma Linda, CA
Funding
This program has been made possible through an educational grant from TEVA Neuroscience.
Faculty Disclosure
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Chen has disclosed the following commercial / financial relationships through Grant / Research Support and / or Consultant Services and / or Speakers’ Bureau: Boehringer Ingelheim, Schwarz Pharma / UCB, and Teva Neuroscience.
Please note: The opinions expressed in this CPE activity should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Accreditation
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-09-016-L01-P has been assigned to this live, knowledge-based, CPE activity (initial release date 03-24-09). This program is approved for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Participants must attend the program and complete a program evaluation online at the ProCE CE Center website to receive pharmacy CE credit. After completing the online evaluation, participants may generate and print their statement of credit at the ProCE CE Center website. No partial credit will be given.
ACPE - Pharmacists Accreditation
|
| Credit Hours: 1 |
Expiration Date: 03/24/2010 |
ACPE UPN: 221-000-09-016-L01-P |
| |
Release Date: 03/24/2009
|
|
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
|
To receive CE credit, participants must complete an online evaluation form for each session attended. After completing the evaluation, you can view, print and track your CE statements of credit online.
There is no fee to participate in this activity.
|
|
The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
|
